Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown120%
completed240%
recruiting120%
enrolling_by_invitation120%

Recent Activity

1 active trials
Showing 5 of 5
enrolling_by_invitation

Health eHeart BioBank

NCT06976502
recruiting

Platform for the Prospective Mother-child Study of the Determinants of Neurodevelopmental Disorders

NCT05681923
unknown

Determinants of the Progression and Outcome of Mitral Regurgitation

NCT01835054
completednot_applicable

Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism

NCT01770548
completed

Molecular Genetics of Schizophrenia

NCT00006418

Clinical Trials (5)

Showing 5 of 5 trials
NCT06976502

Health eHeart BioBank

Enrolling By Invitation
NCT05681923

Platform for the Prospective Mother-child Study of the Determinants of Neurodevelopmental Disorders

Recruiting
NCT01835054

Determinants of the Progression and Outcome of Mitral Regurgitation

Unknown
NCT01770548Not Applicable

Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism

Completed
NCT00006418

Molecular Genetics of Schizophrenia

Completed

All 5 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
5